Compare · EHAB vs HIMS
EHAB vs HIMS
Side-by-side comparison of Enhabit Inc. (EHAB) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EHAB and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.29B, about 8.9x EHAB ($706.9M).
- HIMS has been more active in the news (20 items in the past 4 weeks vs 1 for EHAB).
- HIMS has more recent analyst coverage (25 ratings vs 19 for EHAB).
- Company
- Enhabit Inc.
- Hims & Hers Health Inc.
- Price
- $13.80+0.00%
- $27.18+3.76%
- Market cap
- $706.9M
- $6.29B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NYSE
- IPO
- 2022
- 2019
- News (4w)
- 1
- 20
- Recent ratings
- 19
- 25
Enhabit Inc.
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest EHAB
- SEC Form 15-12G filed by Enhabit Inc.
- SEC Form S-8 POS filed by Enhabit Inc.
- SEC Form S-8 POS filed by Enhabit Inc.
- President and CEO Jacobsmeyer Barbara Ann returned $16,704,541 worth of shares to the company (1,210,474 units at $13.80) and was granted 603,767 shares, closing all direct ownership in the company (SEC Form 4)
- General Counsel and Secretary Black Dylan C returned $2,869,144 worth of shares to the company (207,909 units at $13.80) and was granted 108,086 shares, closing all direct ownership in the company (SEC Form 4)
- EVP of Home Health Operations Jolley Julie Diane returned $3,678,238 worth of shares to the company (266,539 units at $13.80) and was granted 129,409 shares, closing all direct ownership in the company (SEC Form 4)
- Chief Human Resources Officer Marion Tanya Renee returned $2,904,031 worth of shares to the company (210,437 units at $13.80) and was granted 103,674 shares, closing all direct ownership in the company (SEC Form 4)
- EVP of Hospice Operations Kalvaitis Jeanne Louise returned $1,593,900 worth of shares to the company (115,500 units at $13.80) and was granted 53,625 shares, closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Enhabit Inc.
- Director Rodgers Stephan returned $294,464 worth of shares to the company (21,338 units at $13.80), closing all direct ownership in the company (SEC Form 4)
Latest HIMS
- Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
- Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits
- Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians
- Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany
- Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World's Largest Consumer Health Platform
- Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market
- Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform
- Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
- Director Wells David B bought $1,172,974 worth of shares (48,400 units at $24.23), increasing direct ownership by 27% to 224,417 units (SEC Form 4)
- SEC Form 4 filed by Chief Medical Officer Carroll Patrick Harrison